Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis.
van Schouwenburg PA, Rispens T, Wolbink GJ. van Schouwenburg PA, et al. Among authors: rispens t. Nat Rev Rheumatol. 2013 Mar;9(3):164-72. doi: 10.1038/nrrheum.2013.4. Epub 2013 Feb 12. Nat Rev Rheumatol. 2013. PMID: 23399692 Review.
Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions.
Rispens T, Ooievaar-De Heer P, Vermeulen E, Schuurman J, van der Neut Kolfschoten M, Aalberse RC. Rispens T, et al. J Immunol. 2009 Apr 1;182(7):4275-81. doi: 10.4049/jimmunol.0804338. J Immunol. 2009. PMID: 19299726
Label-free assessment of high-affinity antibody-antigen binding constants. Comparison of bioassay, SPR, and PEIA-ellipsometry.
Rispens T, Te Velthuis H, Hemker P, Speijer H, Hermens W, Aarden L. Rispens T, et al. J Immunol Methods. 2011 Feb 28;365(1-2):50-7. doi: 10.1016/j.jim.2010.11.010. Epub 2010 Nov 27. J Immunol Methods. 2011. PMID: 21115013
Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.
Guhr T, Bloem J, Derksen NI, Wuhrer M, Koenderman AH, Aalberse RC, Rispens T. Guhr T, et al. Among authors: rispens t. PLoS One. 2011;6(6):e21246. doi: 10.1371/journal.pone.0021246. Epub 2011 Jun 23. PLoS One. 2011. PMID: 21731683 Free PMC article.
Differential effect of drug interference in immunogenicity assays.
Hart MH, de Vrieze H, Wouters D, Wolbink GJ, Killestein J, de Groot ER, Aarden LA, Rispens T. Hart MH, et al. Among authors: rispens t. J Immunol Methods. 2011 Sep 30;372(1-2):196-203. doi: 10.1016/j.jim.2011.07.019. Epub 2011 Jul 29. J Immunol Methods. 2011. PMID: 21824477
Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testing.
Rispens T, de Vrieze H, de Groot E, Wouters D, Stapel S, Wolbink GJ, Aarden LA. Rispens T, et al. J Immunol Methods. 2012 Jan 31;375(1-2):93-9. doi: 10.1016/j.jim.2011.09.011. Epub 2011 Oct 1. J Immunol Methods. 2012. PMID: 21986105
Immunogenicity of biological therapeutics: from assay to patient.
Krieckaert C, Rispens T, Wolbink G. Krieckaert C, et al. Among authors: rispens t. Curr Opin Rheumatol. 2012 May;24(3):306-11. doi: 10.1097/BOR.0b013e3283521c4e. Curr Opin Rheumatol. 2012. PMID: 22388644 Review.
IgG4 production against adalimumab during long term treatment of RA patients.
van Schouwenburg PA, Krieckaert CL, Nurmohamed M, Hart M, Rispens T, Aarden L, Wouters D, Wolbink GJ. van Schouwenburg PA, et al. Among authors: rispens t. J Clin Immunol. 2012 Oct;32(5):1000-6. doi: 10.1007/s10875-012-9705-0. Epub 2012 May 24. J Clin Immunol. 2012. PMID: 22622790
IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?
Lighaam LC, Aalberse RC, Rispens T. Lighaam LC, et al. Among authors: rispens t. Int J Rheumatol. 2012;2012:789164. doi: 10.1155/2012/789164. Epub 2012 Jun 4. Int J Rheumatol. 2012. PMID: 22701488 Free PMC article.
Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.
van Schouwenburg PA, van de Stadt LA, de Jong RN, van Buren EE, Kruithof S, de Groot E, Hart M, van Ham SM, Rispens T, Aarden L, Wolbink GJ, Wouters D. van Schouwenburg PA, et al. Among authors: rispens t. Ann Rheum Dis. 2013 Jan;72(1):104-9. doi: 10.1136/annrheumdis-2012-201445. Epub 2012 Jul 3. Ann Rheum Dis. 2013. PMID: 22759910
185 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page